Inmode Ltd (INMD)

$14.92 -0.23 (-1.52%)
Market Cap 870.84M
Revenue (ttm) 370.50M
Net Income (ttm) 93.83M
EPS (ttm) N/A
PE Ratio 11.07
Forward PE N/A
Profit Margin 25.33%
Debt to Equity Ratio 0.00
Volume 601,200
Avg Vol 895,638
Day's Range N/A - N/A
Shares Out 57.48M
Stochastic %K 54%
Beta 1.91
Analysts Sell
Price Target $15.60

Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 909 6313
Address:
Tavor Building, Sha’ar Yokneam PO Box 533, Yokne'am, Israel
findingthestock
findingthestock Jul. 15 at 3:06 AM
$INMD
0 · Reply
findingthestock
findingthestock Jul. 15 at 3:01 AM
$INMD Moshe and other Israeli companies known to tank stock value so they can buy cheap and take it private
0 · Reply
findingthestock
findingthestock Jul. 13 at 3:21 PM
$INMD Moshe cancelled investor calls Trying to buy company for cheap InMode Ltd. reports that on July 10, 2026, SP Strategic Holdings LLC, an affiliate of Steel Partners Holdings L.P., filed an urgent application for interim and temporary relief in the Haifa District Court in Israel against the company and its directors. The application seeks to prevent continuation of the special committee’s consideration of a previously disclosed proposal by M.N. Business Strategy Ltd. to acquire all outstanding ordinary shares of InMode not already owned by the proposing group, citing concerns about the directors’ independence in evaluating the proposal. On July 12, 2026, the Court extended to
1 · Reply
newscatch
newscatch Jul. 13 at 2:18 PM
$INMD https://www.prnewswire.com/news-releases/inmode-to-report-second-quarter-2026-financial-results-on-august-5--2026--expects-q2-revenue-between-95-2m-95-4m-reiterates-fy-2026-revenue-guidance-between-365m-375m-302823516.html
0 · Reply
findingthestock
findingthestock Jul. 13 at 1:32 PM
$INMD MOSHE IS CANCELLING CALL Wants to buy coach out for cheap As the Company's Special Committee continues its evaluation of strategic proposals, the Company will not host an investor conference call or webcast in connection with this earnings release and will not be conducting investor meetings at this time.
0 · Reply
onlythebestcompanies
onlythebestcompanies Jul. 13 at 9:27 AM
$INMD $20 soon. Barclays Maintains InMode With Buy Rating, Cuts Target Price to $19
0 · Reply
onlythebestcompanies
onlythebestcompanies Jul. 10 at 1:39 PM
$INMD $18 soon.
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 10 at 12:23 PM
$INMD (+1.4% pre) InMode confirms unsolicited acquisition bid from Steel Partners https://ooc.bz/l/107428
0 · Reply
findingthestock
findingthestock Jul. 10 at 5:14 AM
$INMD Moshe won’t stop until he can take company private for cheap
0 · Reply
_StockFox_
_StockFox_ Jul. 9 at 10:55 PM
$INMD nice $SPY $QQQ
0 · Reply
Latest News on INMD
InMode price target raised to $17 from $14 at Baird

2026-07-14T12:35:44.000Z - 19 hours ago

InMode price target raised to $17 from $14 at Baird

InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

Jul 13, 2026, 7:00 AM EDT - 1 day ago

InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

InMode confirms receipt of unsolicited proposal from Steel Partners

2026-07-10T11:06:25.000Z - 4 days ago

InMode confirms receipt of unsolicited proposal from Steel Partners

InMode Confirms Receipt of Unsolicited Proposal

Jul 10, 2026, 7:00 AM EDT - 4 days ago

InMode Confirms Receipt of Unsolicited Proposal

Steel Partners offers to acquire InMode for $16.75 per share in cash

2026-07-09T12:41:15.000Z - 5 days ago

Steel Partners offers to acquire InMode for $16.75 per share in cash

Steel Partners Offers to Acquire InMode for $16.75 Per Share in Cash

Jul 9, 2026, 8:35 AM EDT - 5 days ago

Steel Partners Offers to Acquire InMode for $16.75 Per Share in Cash

DOMA Perpetual says InMode buyout proposal ‘materially undervalues’ company

2026-06-26T12:36:08.000Z - 18 days ago

DOMA Perpetual says InMode buyout proposal ‘materially undervalues’ company

DOMA PERPETUAL CAPITAL MANAGEMENT STRONGLY OPPOSES INMODE BUYOUT AS PROPOSED; PLANS TO VOTE AGAINST DEAL

Jun 26, 2026, 8:25 AM EDT - 18 days ago

DOMA PERPETUAL CAPITAL MANAGEMENT STRONGLY OPPOSES INMODE BUYOUT AS PROPOSED; PLANS TO VOTE AGAINST DEAL

InMode confirms receipt of unsolicited $16.20 per share takeover proposal

2026-06-24T12:45:47.000Z - 20 days ago

InMode confirms receipt of unsolicited $16.20 per share takeover proposal

InMode Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 12:45 PM EDT - 5 weeks ago

InMode Transcript: Jefferies Global Healthcare Conference 2026

InMode names Moshik Itzkovich as CFO, succeeding Yair Malca

2026-05-20T11:13:31.000Z - 7 weeks ago

InMode names Moshik Itzkovich as CFO, succeeding Yair Malca

InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer

May 20, 2026, 7:00 AM EDT - 7 weeks ago

InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer

InMode to Present at Upcoming Investor Conferences and Events

May 13, 2026, 8:30 AM EDT - 2 months ago

InMode to Present at Upcoming Investor Conferences and Events

InMode price target lowered to $14 from $17 at Baird

2026-05-07T15:55:54.000Z - 2 months ago

InMode price target lowered to $14 from $17 at Baird

InMode price target lowered to $19 from $21 at Barclays

2026-05-07T11:59:20.000Z - 2 months ago

InMode price target lowered to $19 from $21 at Barclays

InMode reports Q1 adjusted EPS 25c, consensus 30c

2026-05-07T08:38:09.000Z - 2 months ago

InMode reports Q1 adjusted EPS 25c, consensus 30c

InMode sees FY26 adjusted EPS $1.33-$1.38, consensus $1.45

2026-05-07T08:36:11.000Z - 2 months ago

InMode sees FY26 adjusted EPS $1.33-$1.38, consensus $1.45

InMode CFO Yair Malca steps down

2026-05-07T08:32:48.000Z - 2 months ago

InMode CFO Yair Malca steps down

InMode Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

InMode Earnings Call Transcript: Q1 2026

InMode Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

InMode Earnings release: Q1 2026

InMode Slides: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

InMode Slides: Q1 2026

InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase

May 6, 2026, 7:00 AM EDT - 2 months ago

InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase

Weight-loss revolution sparks new appetite for aesthetics firms

May 4, 2026, 11:16 AM EDT - 2 months ago

Weight-loss revolution sparks new appetite for aesthetics firms

APYX EOLS ESTA

InMode Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 13, 2026, 11:00 AM EDT - 3 months ago

InMode Transcript: 25th Annual Needham Virtual Healthcare Conference

InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

Apr 13, 2026, 7:00 AM EDT - 3 months ago

InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

InMode to Present at the 25th Annual Needham Virtual Healthcare Conference

Mar 24, 2026, 8:30 AM EDT - 4 months ago

InMode to Present at the 25th Annual Needham Virtual Healthcare Conference

InMode Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 16, 2026, 1:20 PM EDT - 4 months ago

InMode Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

InMode announces new share repurchase program

2026-03-13T11:06:11.000Z - 4 months ago

InMode announces new share repurchase program

InMode Announces New Share Repurchase Program

Mar 13, 2026, 7:00 AM EDT - 4 months ago

InMode Announces New Share Repurchase Program

InMode Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 11, 2026, 12:30 PM EDT - 4 months ago

InMode Transcript: Barclays 28th Annual Global Healthcare Conference

InMode to Present at Upcoming Investor Conferences

Feb 26, 2026, 8:00 AM EST - 4 months ago

InMode to Present at Upcoming Investor Conferences

InMode’s independent transaction committee determines to discontinue process

2026-02-23T12:16:10.000Z - 5 months ago

InMode’s independent transaction committee determines to discontinue process

InMode Announces Conclusion of Independent Transaction Committee Review

Feb 23, 2026, 7:00 AM EST - 5 months ago

InMode Announces Conclusion of Independent Transaction Committee Review

InMode price target raised to $17 from $16 at Baird

2026-02-11T12:06:15.000Z - 5 months ago

InMode price target raised to $17 from $16 at Baird

InMode Earnings Call Transcript: Q4 2025

Feb 10, 2026, 8:30 AM EST - 5 months ago

InMode Earnings Call Transcript: Q4 2025

InMode Earnings release: Q4 2025

Feb 10, 2026, 8:30 AM EST - 5 months ago

InMode Earnings release: Q4 2025

InMode Annual report: Q4 2025

Feb 10, 2026, 8:30 AM EST - 5 months ago

InMode Annual report: Q4 2025

InMode Slides: Q4 2025

Feb 10, 2026, 8:30 AM EST - 5 months ago

InMode Slides: Q4 2025

InMode reports Q4 non-GAAP EPS 46c, consensus 42c

2026-02-10T12:12:18.000Z - 5 months ago

InMode reports Q4 non-GAAP EPS 46c, consensus 42c

InMode sees 2026 non-GAAP EPS $1.43-$1.48, consensus $1.64

2026-02-10T12:11:50.000Z - 5 months ago

InMode sees 2026 non-GAAP EPS $1.43-$1.48, consensus $1.64

InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million

Feb 10, 2026, 7:00 AM EST - 5 months ago

InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million

InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Feb 3, 2026, 8:00 AM EST - 5 months ago

InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

InMode says ‘currently evaluating potential strategic alternatives’

2026-02-02T12:12:45.000Z - 5 months ago

InMode says ‘currently evaluating potential strategic alternatives’

InMode Responds to Transaction Rumors

Feb 2, 2026, 7:00 AM EST - 5 months ago

InMode Responds to Transaction Rumors

Steel Partners presents $18.00 per share offer to acquire 51% of InMode

2026-01-28T22:35:37.000Z - 5 months ago

Steel Partners presents $18.00 per share offer to acquire 51% of InMode

Steel Partners Holdings L.P. Announces It Has Presented $18.00 Per Share Offer for 51% of InMode Ltd.

Jan 28, 2026, 5:30 PM EST - 5 months ago

Steel Partners Holdings L.P. Announces It Has Presented $18.00 Per Share Offer for 51% of InMode Ltd.

InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M

Jan 8, 2026, 7:00 AM EST - 6 months ago

InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M

InMode Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 11:00 AM EST - 8 months ago

InMode Transcript: Jefferies London Healthcare Conference 2025

InMode Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

InMode Earnings Call Transcript: Q3 2025

InMode Earnings release: Q3 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

InMode Earnings release: Q3 2025

InMode Slides: Q3 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

InMode Slides: Q3 2025

InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

Nov 5, 2025, 7:00 AM EST - 8 months ago

InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

InMode Appoints Michael Dennison as President of North America

Nov 3, 2025, 8:05 AM EST - 9 months ago

InMode Appoints Michael Dennison as President of North America

InMode to Participate in Upcoming Investor Conferences

Oct 30, 2025, 8:30 AM EDT - 9 months ago

InMode to Participate in Upcoming Investor Conferences

InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M

Oct 9, 2025, 7:00 AM EDT - 9 months ago

InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M

InMode Transcript: Baird Global Healthcare Conference 2025

Sep 10, 2025, 8:30 AM EDT - 10 months ago

InMode Transcript: Baird Global Healthcare Conference 2025

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders

Sep 9, 2025, 8:15 AM EDT - 11 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders

InMode to Present at Baird 2025 Global Healthcare Conference

Sep 2, 2025, 8:30 AM EDT - 11 months ago

InMode to Present at Baird 2025 Global Healthcare Conference

InMode Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 12, 2025, 2:30 PM EDT - 1 year ago

InMode Transcript: Canaccord Genuity’s 45th Annual Growth Conference

InMode Earnings Call Transcript: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 1 year ago

InMode Earnings Call Transcript: Q2 2025

InMode Earnings release: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 1 year ago

InMode Earnings release: Q2 2025

InMode Slides: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 1 year ago

InMode Slides: Q2 2025

InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins

Jul 30, 2025, 7:00 AM EDT - 1 year ago

InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

Jul 10, 2025, 7:00 AM EDT - 1 year ago

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

InMode Transcript: Jefferies Global Healthcare Conference 2025

Jun 4, 2025, 3:10 PM EDT - 1 year ago

InMode Transcript: Jefferies Global Healthcare Conference 2025

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

May 28, 2025, 8:30 AM EDT - 1 year ago

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

InMode Transcript: BNP Virtual Aesthetics Day

May 19, 2025, 11:00 AM EDT - 1 year ago

InMode Transcript: BNP Virtual Aesthetics Day

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

May 9, 2025, 8:22 AM EDT - 1 year ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges

May 6, 2025, 8:03 AM EDT - 1 year ago

InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges

Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City

Apr 28, 2025, 1:41 PM EDT - 1 year ago

Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City

InMode Earnings Call Transcript: Q1 2025

Apr 28, 2025, 8:30 AM EDT - 1 year ago

InMode Earnings Call Transcript: Q1 2025

InMode Earnings release: Q1 2025

Apr 28, 2025, 8:30 AM EDT - 1 year ago

InMode Earnings release: Q1 2025

InMode Slides: Q1 2025

Apr 28, 2025, 8:30 AM EDT - 1 year ago

InMode Slides: Q1 2025

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease

Apr 28, 2025, 7:00 AM EDT - 1 year ago

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease

InMode Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 8, 2025, 2:15 PM EDT - 1 year ago

InMode Transcript: 24th Annual Needham Virtual Healthcare Conference

InMode to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 26, 2025, 8:30 AM EDT - 1 year ago

InMode to Present at the 24th Annual Needham Virtual Healthcare Conference

InMode Transcript: Oppenheimer 35th Annual Health Care MedTech and Services Conference

Mar 18, 2025, 9:30 AM EDT - 1 year ago

InMode Transcript: Oppenheimer 35th Annual Health Care MedTech and Services Conference

InMode Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 12, 2025, 9:00 AM EDT - 1 year ago

InMode Transcript: Barclays 27th Annual Global Healthcare Conference

InMode Responds to Doma Perpetual's Letters

Mar 6, 2025, 7:30 AM EST - 1 year ago

InMode Responds to Doma Perpetual's Letters

InMode Earnings Call Transcript: Q4 2024

Feb 6, 2025, 8:30 AM EST - 1 year ago

InMode Earnings Call Transcript: Q4 2024

InMode Annual report: Q4 2024

Feb 6, 2025, 8:30 AM EST - 1 year ago

InMode Annual report: Q4 2024

InMode Earnings release: Q4 2024

Feb 6, 2025, 8:30 AM EST - 1 year ago

InMode Earnings release: Q4 2024

InMode Slides: Q4 2024

Feb 6, 2025, 8:30 AM EST - 1 year ago

InMode Slides: Q4 2024

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

Feb 4, 2025, 7:00 AM EST - 1 year ago

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Feb 3, 2025, 8:30 AM EST - 1 year ago

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

Jan 16, 2025, 7:00 AM EST - 1 year ago

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback

Jan 15, 2025, 8:05 AM EST - 1 year ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

Jan 8, 2025, 7:00 AM EST - 1 year ago

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

InMode Transcript: Jefferies London Healthcare Conference 2024

Nov 20, 2024, 6:30 AM EST - 1 year ago

InMode Transcript: Jefferies London Healthcare Conference 2024

InMode Transcript: UBS Global Healthcare Conference 2024

Nov 12, 2024, 5:00 PM EST - 1 year ago

InMode Transcript: UBS Global Healthcare Conference 2024

InMode Earnings Call Transcript: Q3 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

InMode Earnings Call Transcript: Q3 2024

InMode Earnings release: Q3 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

InMode Earnings release: Q3 2024

InMode Slides: Q3 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

InMode Slides: Q3 2024

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

Oct 30, 2024, 7:00 AM EDT - 1 year ago

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

Oct 24, 2024, 7:03 AM EDT - 1 year ago

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

Oct 10, 2024, 7:00 AM EDT - 1 year ago

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy

Oct 1, 2024, 7:00 AM EDT - 1 year ago

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy

InMode Transcript: Baird's 2024 Global Healthcare Conference

Sep 10, 2024, 2:00 PM EDT - 2 years ago

InMode Transcript: Baird's 2024 Global Healthcare Conference

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares

Sep 10, 2024, 7:00 AM EDT - 2 years ago

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares

InMode to Present at 2024 Baird Global Healthcare Conference

Sep 4, 2024, 8:30 AM EDT - 2 years ago

InMode to Present at 2024 Baird Global Healthcare Conference

InMode Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 14, 2024, 2:00 PM EDT - 2 years ago

InMode Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

InMode Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

InMode Earnings Call Transcript: Q2 2024

InMode Earnings release: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

InMode Earnings release: Q2 2024

InMode Slides: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

InMode Slides: Q2 2024

InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M

Aug 1, 2024, 7:00 AM EDT - 2 years ago

InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M

InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform

Jul 31, 2024, 8:03 AM EDT - 2 years ago

InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform

DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer

Jul 25, 2024, 8:15 AM EDT - 2 years ago

DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer

Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling

Jul 17, 2024, 8:03 AM EDT - 2 years ago

Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling

InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024

Jul 11, 2024, 8:30 AM EDT - 2 years ago

InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024

InMode Transcript: Jefferies Global Healthcare Conference

Jun 5, 2024, 7:30 AM EDT - 2 years ago

InMode Transcript: Jefferies Global Healthcare Conference

InMode to Present at Jefferies Healthcare Conference

May 16, 2024, 8:00 AM EDT - 2 years ago

InMode to Present at Jefferies Healthcare Conference

findingthestock
findingthestock Jul. 15 at 3:06 AM
$INMD
0 · Reply
findingthestock
findingthestock Jul. 15 at 3:01 AM
$INMD Moshe and other Israeli companies known to tank stock value so they can buy cheap and take it private
0 · Reply
findingthestock
findingthestock Jul. 13 at 3:21 PM
$INMD Moshe cancelled investor calls Trying to buy company for cheap InMode Ltd. reports that on July 10, 2026, SP Strategic Holdings LLC, an affiliate of Steel Partners Holdings L.P., filed an urgent application for interim and temporary relief in the Haifa District Court in Israel against the company and its directors. The application seeks to prevent continuation of the special committee’s consideration of a previously disclosed proposal by M.N. Business Strategy Ltd. to acquire all outstanding ordinary shares of InMode not already owned by the proposing group, citing concerns about the directors’ independence in evaluating the proposal. On July 12, 2026, the Court extended to
1 · Reply
newscatch
newscatch Jul. 13 at 2:18 PM
$INMD https://www.prnewswire.com/news-releases/inmode-to-report-second-quarter-2026-financial-results-on-august-5--2026--expects-q2-revenue-between-95-2m-95-4m-reiterates-fy-2026-revenue-guidance-between-365m-375m-302823516.html
0 · Reply
findingthestock
findingthestock Jul. 13 at 1:32 PM
$INMD MOSHE IS CANCELLING CALL Wants to buy coach out for cheap As the Company's Special Committee continues its evaluation of strategic proposals, the Company will not host an investor conference call or webcast in connection with this earnings release and will not be conducting investor meetings at this time.
0 · Reply
onlythebestcompanies
onlythebestcompanies Jul. 13 at 9:27 AM
$INMD $20 soon. Barclays Maintains InMode With Buy Rating, Cuts Target Price to $19
0 · Reply
onlythebestcompanies
onlythebestcompanies Jul. 10 at 1:39 PM
$INMD $18 soon.
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 10 at 12:23 PM
$INMD (+1.4% pre) InMode confirms unsolicited acquisition bid from Steel Partners https://ooc.bz/l/107428
0 · Reply
findingthestock
findingthestock Jul. 10 at 5:14 AM
$INMD Moshe won’t stop until he can take company private for cheap
0 · Reply
_StockFox_
_StockFox_ Jul. 9 at 10:55 PM
$INMD nice $SPY $QQQ
0 · Reply
notreload_ai
notreload_ai Jul. 9 at 7:56 PM
Steel Partners has submitted a $16.75 per share bid for $INMD, surpassing the CEO-backed $16.20 offer. The firm criticizes CEO Moshe Mizrahy and urges the board to act. https://notreload.xyz/xy/steel-partners-launches-16-75-takeover-bid-for-inmode/
0 · Reply
findingthestock
findingthestock Jul. 9 at 3:07 PM
$INMD yes they all have history like this Very bad
0 · Reply
Paardaam
Paardaam Jul. 9 at 2:53 PM
$INMD rhetoric never changes with isrealie companies . Management out there to screw shareholder for their gain . Never invest in Israel . It rarely turns out to be good story . Always ends up painful . Lessons learned .
1 · Reply
findingthestock
findingthestock Jul. 9 at 2:51 PM
$INMD exactly very low offers to take company private and shareholders get screwed badly
1 · Reply
findingthestock
findingthestock Jul. 9 at 2:50 PM
$INMD THIS ALL BAD FOR SHAREHOLDERS these all low ball offers Steel Partners’ $16.75 per share offer for 100% of InMode would mean the company goes private and is delisted from Nasdaq if it is successfully completed 1. If the board accepts (or shareholders tender enough shares) and the deal closes, InMode would no longer have publicly traded shares. 2. It would be delisted from Nasdaq. 3. The company becomes privately held by Steel Partners (with any rollover participants as co-owners in the private entity).
0 · Reply
Remmers
Remmers Jul. 9 at 2:03 PM
$INMD Steel Partners letter to INMD rips the CEO to shreds. Thankful we have these guys speaking up for all the shareholders. All of this is good for shareholders as a new higher floor price has been set. Expect to see some competition in the bids now, driving up the price.
0 · Reply
The_Stoic_Investor
The_Stoic_Investor Jul. 9 at 2:02 PM
$INMD Well played Steel Partners. Let's trigger a bidding war. Great strategic move on their part. Let it go to the highest bidder!!
0 · Reply
Paardaam
Paardaam Jul. 9 at 1:44 PM
$INMD who is now trying to steal this company for Pennies? This is still company with positive earnings , lotsa cash with no debt . Yes it has not been growing as expected but definitely worth high $20 s at the least . -anything less then $25 should be a joke .
0 · Reply
Swayz99
Swayz99 Jul. 9 at 1:01 PM
7/9 WL -> $VRAX (leader w/ news, ww break of PM highs for scalp plays) $GMEX (ww break of $3 at open for scalp plays, needs vol first) $TDTH (news, needs volume, only ww over $2.50 imo) $INMD (news, also needs volume but nice range on this) Some decent PM action this morning with small caps. Still not seeing massive action but there are definitely opportunities. Will be patient at the open and wait for those A-quality setups. $VRAX definitely has the attention atm but may be a bit too crowded and choppy. Trade the plan. Happy Huntin'!
0 · Reply
caprihunter
caprihunter Jul. 9 at 12:51 PM
$INMD $CCHH $AFJK $YHC $BYRN
0 · Reply
caprihunter
caprihunter Jul. 9 at 12:48 PM
$INMD $VRAX $RKTO $AEHL
0 · Reply
newscatch
newscatch Jul. 9 at 12:43 PM
$INMD https://www.businesswire.com/news/home/20260709185983/en/Steel-Partners-Offers-to-Acquire-InMode-for-%2416.75-Per-Share-in-Cash
0 · Reply